746 related articles for article (PubMed ID: 18809924)
1. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics.
Cideciyan AV; Aleman TS; Boye SL; Schwartz SB; Kaushal S; Roman AJ; Pang JJ; Sumaroka A; Windsor EA; Wilson JM; Flotte TR; Fishman GA; Heon E; Stone EM; Byrne BJ; Jacobson SG; Hauswirth WW
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15112-7. PubMed ID: 18809924
[TBL] [Abstract][Full Text] [Related]
2. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness.
Acland GM; Aguirre GD; Bennett J; Aleman TS; Cideciyan AV; Bennicelli J; Dejneka NS; Pearce-Kelling SE; Maguire AM; Palczewski K; Hauswirth WW; Jacobson SG
Mol Ther; 2005 Dec; 12(6):1072-82. PubMed ID: 16226919
[TBL] [Abstract][Full Text] [Related]
3. Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success.
Jacobson SG; Aleman TS; Cideciyan AV; Sumaroka A; Schwartz SB; Windsor EA; Traboulsi EI; Heon E; Pittler SJ; Milam AH; Maguire AM; Palczewski K; Stone EM; Bennett J
Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6177-82. PubMed ID: 15837919
[TBL] [Abstract][Full Text] [Related]
4. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.
Hauswirth WW; Aleman TS; Kaushal S; Cideciyan AV; Schwartz SB; Wang L; Conlon TJ; Boye SL; Flotte TR; Byrne BJ; Jacobson SG
Hum Gene Ther; 2008 Oct; 19(10):979-90. PubMed ID: 18774912
[TBL] [Abstract][Full Text] [Related]
5. Bax-induced apoptosis in Leber's congenital amaurosis: a dual role in rod and cone degeneration.
Hamann S; Schorderet DF; Cottet S
PLoS One; 2009 Aug; 4(8):e6616. PubMed ID: 19672311
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Amelioration of Cone Survival and Vision in a Mouse Model for Leber Congenital Amaurosis.
Li S; Samardzija M; Yang Z; Grimm C; Jin M
J Neurosci; 2016 May; 36(21):5808-19. PubMed ID: 27225770
[TBL] [Abstract][Full Text] [Related]
7. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial.
Bennett J; Wellman J; Marshall KA; McCague S; Ashtari M; DiStefano-Pappas J; Elci OU; Chung DC; Sun J; Wright JF; Cross DR; Aravand P; Cyckowski LL; Bennicelli JL; Mingozzi F; Auricchio A; Pierce EA; Ruggiero J; Leroy BP; Simonelli F; High KA; Maguire AM
Lancet; 2016 Aug; 388(10045):661-72. PubMed ID: 27375040
[TBL] [Abstract][Full Text] [Related]
8. Human cone photoreceptor dependence on RPE65 isomerase.
Jacobson SG; Aleman TS; Cideciyan AV; Heon E; Golczak M; Beltran WA; Sumaroka A; Schwartz SB; Roman AJ; Windsor EA; Wilson JM; Aguirre GD; Stone EM; Palczewski K
Proc Natl Acad Sci U S A; 2007 Sep; 104(38):15123-8. PubMed ID: 17848510
[TBL] [Abstract][Full Text] [Related]
9. Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation.
Aguirre GK; Komáromy AM; Cideciyan AV; Brainard DH; Aleman TS; Roman AJ; Avants BB; Gee JC; Korczykowski M; Hauswirth WW; Acland GM; Aguirre GD; Jacobson SG
PLoS Med; 2007 Jun; 4(6):e230. PubMed ID: 17594175
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis.
Bemelmans AP; Kostic C; Crippa SV; Hauswirth WW; Lem J; Munier FL; Seeliger MW; Wenzel A; Arsenijevic Y
PLoS Med; 2006 Oct; 3(10):e347. PubMed ID: 17032058
[TBL] [Abstract][Full Text] [Related]
11. Loss of cone photoreceptors caused by chromophore depletion is partially prevented by the artificial chromophore pro-drug, 9-cis-retinyl acetate.
Maeda T; Cideciyan AV; Maeda A; Golczak M; Aleman TS; Jacobson SG; Palczewski K
Hum Mol Genet; 2009 Jun; 18(12):2277-87. PubMed ID: 19339306
[TBL] [Abstract][Full Text] [Related]
12. Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis.
Jacobson SG; Boye SL; Aleman TS; Conlon TJ; Zeiss CJ; Roman AJ; Cideciyan AV; Schwartz SB; Komaromy AM; Doobrajh M; Cheung AY; Sumaroka A; Pearce-Kelling SE; Aguirre GD; Kaushal S; Maguire AM; Flotte TR; Hauswirth WW
Hum Gene Ther; 2006 Aug; 17(8):845-58. PubMed ID: 16942444
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy rescues cone structure and function in the 3-month-old rd12 mouse: a model for midcourse RPE65 leber congenital amaurosis.
Li X; Li W; Dai X; Kong F; Zheng Q; Zhou X; Lü F; Chang B; Rohrer B; Hauswirth WW; Qu J; Pang JJ
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):7-15. PubMed ID: 21169527
[TBL] [Abstract][Full Text] [Related]
14. Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle.
Redmond TM; Poliakov E; Yu S; Tsai JY; Lu Z; Gentleman S
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13658-63. PubMed ID: 16150724
[TBL] [Abstract][Full Text] [Related]
15. Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness.
Van Hooser JP; Aleman TS; He YG; Cideciyan AV; Kuksa V; Pittler SJ; Stone EM; Jacobson SG; Palczewski K
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8623-8. PubMed ID: 10869443
[TBL] [Abstract][Full Text] [Related]
16. Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy.
Cideciyan AV
Prog Retin Eye Res; 2010 Sep; 29(5):398-427. PubMed ID: 20399883
[TBL] [Abstract][Full Text] [Related]
17. Nrl-knockout mice deficient in Rpe65 fail to synthesize 11-cis retinal and cone outer segments.
Feathers KL; Lyubarsky AL; Khan NW; Teofilo K; Swaroop A; Williams DS; Pugh EN; Thompson DA
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1126-35. PubMed ID: 18326740
[TBL] [Abstract][Full Text] [Related]
18. Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency.
Pang J; Boye SE; Lei B; Boye SL; Everhart D; Ryals R; Umino Y; Rohrer B; Alexander J; Li J; Dai X; Li Q; Chang B; Barlow R; Hauswirth WW
Gene Ther; 2010 Jul; 17(7):815-26. PubMed ID: 20237510
[TBL] [Abstract][Full Text] [Related]
19. In utero gene therapy rescues vision in a murine model of congenital blindness.
Dejneka NS; Surace EM; Aleman TS; Cideciyan AV; Lyubarsky A; Savchenko A; Redmond TM; Tang W; Wei Z; Rex TS; Glover E; Maguire AM; Pugh EN; Jacobson SG; Bennett J
Mol Ther; 2004 Feb; 9(2):182-8. PubMed ID: 14759802
[TBL] [Abstract][Full Text] [Related]
20. Remaining rod activity mediates visual behavior in adult Rpe65-/- mice.
Cachafeiro M; Bemelmans AP; Canola K; Pignat V; Crippa SV; Kostic C; Arsenijevic Y
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6835-42. PubMed ID: 20702833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
